Media

April 9, 2025: MaaT Pharma reports safety interim analysis from trial of microbiome therapy – Clinical Trials Arena

Date : April 9, 2025

Lien vers le média

April 9, 2025: Investigational Microbiotherapy MaaT033 Is Safe in Allo-HSCT Recipients – OncLive

April 14, 2025: Availability of MaaT Pharma’s 2024 Universal Registration Document (URD)